I. INTRODUCTION
ders, including non-insulin-dependent diabetes, hypertension, cancer, gallbladder disease, and atherosclerosis. White adipose tissue (WAT) is the major energy re-With regard to this wide range of health implications, the serve in higher eukaryotes, and storing triacylglycerol in need to develop new and effective strategies in controlling periods of energy excess and its mobilization during en-obesity has become more acute. Recently, progress has ergy deprivation are its primary purposes. Recently, there been made in understanding the process of adipocyte difhas been a dramatic increase in the incidence of obesity ferentiation and in the cloning of genes mutated in several resulting from an excess of WAT. Obesity is a prevalent monogenic mouse models of obesity. This has not only health hazard in industrialized countries (145, 298) and is allowed us to begin to understand the cellular and molecular basis of adipose tissue growth in physiological and closely associated with a number of pathological disor-pathophysiological states, but has also provided means mal serum, and its secretion is enhanced by insulin. This suggests that it could function as a signaling molecule to develop therapeutic strategies for the treatment and prevention of obesity. This review addresses regulation from adipocytes and might therefore regulate energy homeostasis (119, 229). As addressed in detail in section of WAT development at the cellular and molecular levels. We summarize information gained from studies in preadi-VIA, TNF-a not only inhibits adipocyte differentiation, but treatment of mature adipocytes with TNF-a reduces the pocyte cell lines and attempt to incorporate results from often neglected primary preadipocyte studies.
expression of adipocyte genes (202, 259, 260, 273, 274) . In addition, TNF-a may contribute to the insulin resistance that accompanies obesity and non-insulin-depen-II. ADIPOSE TISSUE AS A SECRETORY ORGAN dent diabetes mellitus; TNF-a levels are elevated in WAT of obese rodents and humans. This may contribute to insulin resistance by inhibiting insulin-stimulated tyrosine Mature adipocytes, the main cellular component of WAT, are uniquely equipped to function in energy storage kinase activity of the insulin receptor (114) (115) (116) (117) 135) .
Treatment of adipocytes with TNF-a was recently reand balance under tight hormonal control. However, with the recent realization that adipocytes secrete factors ported to increase secretion of MIF, a proinflammatory cytokine. Therefore, MIF may mediate the above-menknown to play a role in immunological responses, vascular diseases, and appetite regulation, a much more complex tioned contribution of TNF-a to insulin resistance (112).
Vascular function-related proteins that are secreted and dynamic role of WAT has progressively emerged. Leptin, the obese (ob) gene product, is a hormone that is by adipocytes include angiotensinogen and plasminogen activator inhibitor type 1 (PAI-1). White adipose tissue primarily made and secreted by mature adipocytes and binds to its receptor in the hypothalamus. Studies indicate contains all the main components of the renin-angiotensin system such as angiotensinogen, angiotensin converting leptin may function in regulating body fat mass. Loss of fat stores decreases leptin levels and increases neuropep-enzyme, angiotensin II, and angiotensin receptors (130) .
Angiotensinogen could play a role in regulating adipose tide Y levels; this leads to increased food intake. Conversely, weight gain increases leptin levels leading to de-tissue blood supply and fatty acid efflux from fat (73).
Angiotensin II, the cleavage product of angiotensinogen, creased food intake; melanocyte-stimulating hormone is necessary for this response (31, 201). Leptin levels are has been implicated in adipose tissue growth by stimulating production of prostacyclin by mature fat cells and elevated in human obesity and in animal models of obesity. More recently, the leptin receptor has been detected thereby promoting adipocyte differentiation via a paracrine/autocrine mechanism (53) . Because angiotensin II in peripheral tissues. This suggests additional roles for leptin, including modulation of insulin action in liver (45) , increases lipogenesis in both human and 3T3-L1 adipocytes, it may also be involved in the control of adiposity production of steroids in the ovary (310) , and direct effects on adrenocortical steroidogenesis (23). Leptin also through regulation of lipid synthesis and storage in adipocytes (127) . Plasminogen activator inhibitor type 1 is prohas a role in reproductive physiology (39, 178) and is involved in hematopoietic and immune system develop-duced by adipose tissue, and treatment of 3T3-L1 adipocytes with transforming growth factor-b (TGF-b) signifiment (18, 173) . This rapidly growing list, clearly not exhaustive, indicates that leptin has a much broader range cantly increases PAI-1 production. Higher PAI-1 levels have been reported in omental fat compared with subcutaof action than initially perceived.
Immune system-related proteins produced by adipo-neous fat. This may be correlated with increased PAI-1 levels noted in central obesity and may be involved in the cytes include adipsin, acylation stimulation protein (ASP), adipocyte complement-related protein (Acrp30/AdipoQ), development of vascular diseases associated with abdominal obesity (5, 164, 241) . tumor necrosis factor-a (TNF-a), and macrophage migration inhibitory factor (MIF). With the exception of TNFTaken together, these studies clearly establish that the adipocyte behaves as an endocrine as well as a paraa, their physiological function remains to be elucidated. Nonetheless, these adipocyte-derived factors might also crine/autocrine cell. Along with its active role in regulating energy balance, WAT has the potential to play a dynamic be involved in either the control of energy homeostasis or insulin resistance. Acylation stimulation protein is gen-role in a variety of other physiological processes, including the autoregulation of adipose tissue growth and develerated by the interaction of complement factor D (identical to adipsin), factor B, and complement C3, components opment. of the alternate complement pathway (41); ASP may be involved in regulating energy storage by stimulating triac-III. ORIGIN OF ADIPOSE CELLS AND ylglycerol synthesis and glucose transport (44, 168, 252) .
ADIPOSE TISSUE Acrp30/AdipoQ displays sequence homology with C1q, the first component of the classical complement activation
The origins of the adipose cell and adipose tissue are still poorly understood, and the molecular events leading pathway. Like adipsin, Acrp30/AdipoQ is abundant in nor-to the commitment of the embryonic stem cell precursor isome proliferator-activated receptor-g (PPAR-g), an adipogenic transcription factor described in section VIIA, reto the adipocyte lineage remain to be characterized. In most species, WAT formation begins before birth, as as-duce bone marrow density and increase bone marrow adipocytes (84) . Teratocarcinoma-derived C1 cells also sessed by morphological studies performed on human, pig, mouse, and rat embryos (59, 204, 205, 245) . The chro-behave as progenitor cells with osteoblast, chondroblast, or adipoblast cell fates (206) . This suggests a close ontogenology of WAT appearance, however, is strictly dependent on the species as well as the adipose depot (59, 218, 245) . netic relationship between these connective tissue cell types. Osteogenic, chondrogenic, and adipogenic cells White adipose tissue expansion takes place rapidly after birth as a result of increased fat cell size as well as an may arise from sclerotomal cells. The recent cloning of the basic-helix-loop-helix (bHLH) transcription factors increase in fat cell number. Even at the adult stage, the potential to generate new fat cells persists. It has been twist and scleraxis has provided hints about the initial events that might precede and/or lead to the formation of demonstrated that fat cell number can increase when rats are fed a high-carbohydrate or high-fat diet (67, 68, 176) . the adipose lineage. In mouse embryo, these genes appear to play a significant role in the development of mesoderIncrease in fat cell number is also observed in severe human obesity. However, the relative contribution of fat mal tissues. Twist is expressed in early somites, and its expression is restricted to the sclerotome and excluded cell size and fat cell number to human adipose tissue growth on nutritional stimulation remains to be clarified. from myotome upon somite compartmentalization. Twist may be essential for the establishment of mesodermal Regardless, early differentiation markers of adipocyte differentiation can be detected even in adipose tissue de-cell fate and may be involved in the subdivision of the mesoderm lineage later in development (85) . Significant rived from very old mice (138) . Moreover, fat cell precursors isolated from adult WAT of various species, including levels of scleraxis can only be detected after somite compartmentalization, when it is expressed in sclerotome but humans, can be differentiated in vitro into mature adipocytes (21, 58, 98, 104, 160, 213, 264) . The potential to not in myotome. Scleraxis could be a regulator of gene expression within the mesenchymal cell lineages that give acquire new fat cells from fat cell precursors throughout the life span is now undisputed.
rise to connective tissues (50) . The precise role of these genes in adipocyte determination remains to be estabAlthough the developmental origin of fat cells is not known, several studies on multipotent clonal cell lines lished. have suggested that the adipocyte lineage derives from an embryonic stem cell precursor with the capacity to IV. IN VITRO MODELS OF ADIPOCYTE differentiate into the mesodermal cell types of adipocytes, DIFFERENTIATION chondrocytes, osteoblasts, and myocytes. Treatment of the murine embryonic cell line C3H10T1/2 with a demethylating agent generates loci of muscle, cartilage, and fat For the past 20 years, in vitro systems have been extensively used to study adipocyte differentiation. This cells (143, 265); 25% of colonies contained myofibers, 7% adipocytes, and 1% chondrocytes. The C3H10T1/2 cells has led to a dissection of the molecular and cellular events taking place during the transition from undifferentiated may represent multipotential stem cells that are blocked at the mesodermal pathway. That a single gene could con-fibroblast-like preadipocytes into a mature round fat cells.
Various preadipose cell lines and primary cultures of adivert C3H10T1/2 cells into myoblasts has been demonstrated with the identification and characterization of the pose-derived stromal vascular precursor cells have been used. Table 1 summarizes the characteristics of the most MyoD family of regulatory genes (54) . The lower clonal frequency of conversion of C3H10T1/2 cells to adipocytes commonly employed preadipose cell models. Preadipose cell lines as well as primary preadipocytes are already as compared with myocytes may indicate that more genes are required to activate adipocyte development. However, committed solely to the adipocyte lineage, although they may represent different stages of adipocyte development. these different frequencies of conversion may also somewhat reflect culture conditions that could selectively pro-The most frequently employed cell lines are 3T3-F442A and 3T3-L1. These were clonally isolated from Swiss 3T3 mote the differentiation of one cell lineage over another. There is also evidence that a common bone marrow stro-cells derived from disaggregated 17-to 19-day mouse embryos (89, 90, 92) . 3T3-C2 cells derive from the same mal cell type may give rise to adipogenic or osteogenic cells with several indications of a reciprocal relationship source but are not preadipocyte in nature. They do not differentiate into adipocytes and can be used to compare in the differentiation of these two cell types (84) . For example, bone morphogenetic proteins of the TGF-b su-the responses of differentiation-defective with differentiation-competent cell types. The TA1 cell line was estabperfamily act as potent osteogenic agonists (83) , whereas TGF-b inhibits adipocyte differentiation, as discussed in lished by treating CH310T1/2 mouse embryo fibroblast cells with the demethylating agent 5-azacytidine (37, 143, section VIA. Furthermore, the antidiabetic compounds thiazolidinediones, recently discovered to act through perox-265). Ob17 cells and their derivatives were generated from The most frequently used in vitro models of adipocyte differentiation are summarized. § General comments on primary cultures: committed to adipocyte lineage and most likely correspond to a later stage of adipocyte development than preadipose cell lines; extent of differentiation depends on age of donor and fat depot; and clonal expansion step appears to be not critical for human preadipocyte differentiation (63) . FBS, fetal bovine serum; MIX, methylisobutylxanthine; Dex, dexamethasone; HDL, high-density lipoprotein; T 3 , 3,3,5-triiodothyronine. * Totipotent cell line. † Multipotent. ‡ Already committed to adipocyte lineage.
adipose precursors present in the epididymal fat pads of the potential cellular heterogeneity of the stromal vascular preadipose cell population is a drawback of primary genetically obese (ob/ob) adult mice (187). In addition to these models, embryonic stem (ES) cells have recently cultures. This, however, may be a minor concern, since nearly 100% differentiation can be achieved when preadibeen shown to differentiate into mature adipocytes in vitro (52) and will likely provide a useful system for in-pocytes derived from young animals are adequately treated (57, 97, 236) . For primary preadipocyte cultures, vestigating the initial steps of adipogenesis. In vitro-differentiated adipocytes have many characteristics of adipose differentiation capacity is clearly donor dependent and decreases significantly with age (21, 58, 98, 138) . The mocells in vivo. Subcutaneous injection of preadipose cells in nude mice leads to development of mature fat pads lecular basis for this reduced differentiation capacity is not known. It may, however, indicate that preadipose cells that are histologically indistinguishable from WAT; this is convincing evidence that adipose cell acquisition occurs derived from aged donors represent a subpopulation of precursor cells arrested at distinct stage(s) of adipocyte by a similar mechanism in vivo (91, 278) .
Because the stage of differentiation and the lineage development. These cells may therefore require a different subset of as yet to be characterized signals to undergo of preadipocyte cell lines have not been well established, primary cultures have been particularly useful for validat-adipocyte differentiation (63, 98) .
During the growth phase, cells of preadipocyte lines ing results obtained in preadipose cell lines. Primary preadipocytes have been successfully cultured from a num-as well as primary preadipocytes are morphologically similar to fibroblasts. At confluence, induction of differentiation ber of species including humans and have several advantages over preadipose cell lines (96-98, 104, 106, 138, 160 , by appropriate treatment leads to drastic cell shape changes. The preadipocyte converts to a spherical shape, 191, 236). Primary cells are diploid and may therefore reflect the in vivo context better than aneuploid cell lines. accumulates lipid droplets, and progressively acquires the morphological and biochemical characteristics of the maSecond, they can be derived from adipose tissue obtained from various species at different postnatal stages of devel-ture white adipocyte. The nature of the induction is dependent on the specific cell culture model system employed. opment and from various adipose depots (21, 57, 58). The latter is of particular interest, since molecular and bio-A variety of differentiation protocols have been developed for preadipose cell lines and for primary preadipocytes. chemical differences in fat pads have been observed (96, 150, 151, 169, 212, 308) . Such differences may have major Embryonic stem cells can be differentiated into adipocytes at high efficiency in vitro if early-developing ES cell-derived physiological consequences, since excessive centralized fat accumulation (upper body obesity) is associated with embryoid bodies are exposed to retinoic acid (RA) for a precise time, followed by treatment with standard adipoincreased morbidity in humans (139) . On the other hand, genic hormones (52) . 3T3-L1 preadipocytes spontaneously pression of numerous genes. This is reflected by the appearance of early, intermediate, and late mRNA/protein differentiate over a period of several weeks into fat-cell clusters when maintained in culture with fetal calf serum. markers and triglyceride accumulation. These changes take place primarily at the transcriptional level, although This can be accelerated by the inducing agents dexamethasone and methylisobutylxanthine (MIX), a phosphodiester-posttranscriptional regulation occurs for some adipocyte genes (180, 295) . In addition to the activation of genes, ase inhibitor. High concentrations of insulin have been used in combination with these inducing agents. The identifica-those genes that are inhibitory to adipogenesis or simply unnecessary for adipose cell function are repressed. tion of agents that accelerate differentiation, but that are not required to maintain the differentiated phenotype, provides Changes in gene expression during the early and late stages of adipocyte maturation have been characterized insights to the biochemical pathways that may function during adipocyte differentiation.
mainly through the use of preadipose cell lines. These have been extensively reviewed by others (47, 166, 249) Although preadipocytes from various sources are similar in many regards, their responsiveness to inducing and are summarized below. The limited information that is available on the details of the molecular events occurring agents varies considerably. This may represent differences in the stage of maturation at which the preadipo-during primary preadipocyte differentiation is also incorporated. cytes were originally harvested during cloning of cell lines or the age and/or source of tissue from which primary cells are isolated. The effects of the various inducing A. Growth Arrest agents on adipocyte differentiation are discussed in detail in section VI. In most cases, primary preadipocytes derived from young animals require only either low concentraIn preadipose cell lines as well as in primary preadipocytes, growth arrest and not cell confluence or celltions (1-10 nM) of insulin in the presence of fetal calf serum, or high concentrations (1-10 mM) in serum-free cell contact per se appears to be required for adipocyte differentiation. Confluent 3T3-F442A cells shifted to medium (57, 97, 104, 264) . Depending on the species, the age of the donor, and/or the adipose depot source, agents methylcellulose-stabilized suspension culture still undergo differentiation (196) . This indicates that although such as glucocorticoids and MIX are either necessary to trigger the differentiation program or act only to acceler-confluence in these cells leads to growth arrest, cell-cell contact is not a prerequisite for adipocyte conversion. ate it (57, 58, 96, 97, 104, 264, 293, 309) . For established cell lines as well as for primary cells, the development of Primary rat preadipocytes plated at low density in serumfree medium can also differentiate in the absence of cellserum-free culture conditions has confirmed the positive role of these inducers and the involvement of insulin-cell contact (277). Two transcription factors, CCAAT/enhancer binding protein a (C/EBP-a) and PPAR-g, have like growth factor I (IGF-I), glucocorticoid, and cAMP signaling pathways. For preadipose cell lines, addition of been shown to transactivate adipocyte specific genes, and are discussed in section VII. Both C/EBP-a and PPAR-g insulin at supraphysiological concentrations does not affect the number of differentiated cells but does serve to also appear to be involved in the growth arrest that is required for adipocyte differentiation. McKnight and coaccelerate lipid accumulation. In contrast, for most primary preadipocytes, which have a very low degree of workers (276) have demonstrated the antimitotic activity of C/EBP-a through the use of a C/EBP-a-estrogen recepspontaneous differentiation, insulin increases the number of differentiated cells; few lipid-containing cells are ob-tor fusion protein. Activation by estrogen treatment results in cessation of cell growth as assessed by cell numserved in the absence of insulin (95, 104, 264) . Depending on the culture system, the insulin/IGF-I signaling pathway ber and DNA synthesis (276). Darlington and co-workers (268) have reported that C/EBP-a increases p21/SDI-1 may either be critical for differentiation or necessary only to achieve the maximal rate of triacylglycerol accumula-mRNA and protein levels, but not other cell cycle components. Moreover, antisense p21/SDI-1 eliminates growth tion that accompanies adipocyte differentiation.
inhibition brought about by C/EBP-a (268). This indicates that C/EBP-a may function by increasing p21/SDI-1 levels.
V. PROCESS OF ADIPOCYTE
Spiegelman and colleagues (6) have showed that PPAR-g DIFFERENTIATION is sufficient to induce growth arrest in fibroblasts and in adipogenic simian virus 40 large T antigen-transformed cells. In these PPAR-g-expressing cells, cell cycle withAn overview of the stages of adipocyte differentiation is presented in Figure 1 . The committed preadipocyte drawal is accompanied by a decrease in the DNA binding and transcriptional activity of the E2F/DP-1 complex bemaintains the capacity for growth but has to withdraw from the cell cycle before adipose conversion. During adi-cause of phosphorylation of DP-1 and a decrease in the expression of the serine/threonine phosphatase PP2A catpocyte differentiation, acquisition of the adipocyte phenotype is characterized by chronological changes in the ex-alytic subunit. Therefore, C/EBP-a and PPAR-g may act FIG . 1 . Overview of stages in adipocyte differentiation. Our current understanding of adipocyte differentiation indicates that a pluripotent stem cell precursor gives rise to a mesenchymal precursor cell with the potential to differentiate along mesodermal lineages of myoblast, chondroblast, osteoblast, and adipocyte. As discussed in text, given appropriate environmental and gene expression cues, preadipocytes undergo clonal expansion and subsequent terminal differentiation. Selected molecular events accompanying this process are indicated to right, with their approximate duration reflected by the solid line. PPAR-g, peroxisome proliferator-activated receptor-g; C/EBP, CCAAT/enhancer binding protein; pref-1, preadipocyte factor-1; ECM, extracellular matrix; FA, fatty acid.
derived from human adipose tissue do not require cell cooperatively to bring about growth arrest (6). Although division to enter the differentiation process (63) . In these C/EBP-a and PPAR-g expression increases dramatically cells, inhibition of mitosis with cytosine arabinoside does during adipocyte differentiation, the low level of these not impair adipocyte development, indicating that clonal factors expressed in preadipocytes may be sufficient to amplification of committed cells is not a critical step. mediate growth arrest that precedes differentiation.
These cells may have already undergone potential critical cell divisions in vivo and may therefore correspond to a B. Clonal Expansion later stage of adipocyte development. Examination of growth-related proteins indicates poAfter growth arrest at confluence, preadipocytes tential differences between clonal expansion and preconmust receive an appropriate combination of mitogenic fluent cell growth in 3T3-L1 preadipocytes. Retinoblasand adipogenic signals to continue through subsequent toma proteins pRB, p107, and p130 bind the E2F/DP comdifferentiation steps. Studies on preadipose cell lines have plex to inactivate growth-promoting transcriptional shown that growth-arrested cells undergo at least one activities. A recent report indicates changes in the expresround of DNA replication and cell doubling. This has been sion of retinoblastoma proteins during differentiation of proposed to lead to the clonal amplification of committed 3T3-L1 cells, including a transient increase in p107. This cells (196) . For 3T3-F442A and Ob17 cells, an increase in appears specific to clonal expansion, since this change is DNA synthesis precedes expression of late mRNA mark-not detected during serum-stimulated cell growth (217) . ers, and inhibition of DNA synthesis prevents the forma-The role of E2F and RB family members during adipogenesis is unknown and needs further examination. Similarly, tion of fat cells (9, 147). However, primary preadipocytes another group of growth arrest-specific (gas) genes shows dent of the additional agents required for adipocyte differentiation, classification of LPL as an early marker of adia distinct expression pattern during clonal expansion. Gas6 appears to be preferentially expressed during clonal pocyte differentiation remains somewhat questionable.
At least two families of transcription factors, C/EBP expansion of postconfluent preadipocytes, whereas gas1 and gas3 are expressed in serum-starved preadipocytes and PPAR, are induced early during adipocyte differentiation. The early expression of C/EBP and PPAR is logical (244) . Combined, these observations suggest differential regulation of the cell cycle in preconfluent proliferation given their subsequent involvment in terminal differentiation by transactivation of adipocyte-specific genes, deversus postconfluent hormonally stimulated clonal expansion. An intracellular receptor for the immunosuppressive scribed in section VII. Peroxisome proliferator-activated receptor-g is largely adipocyte specific and is expressed at drug FK506, FKBP51, also transiently accumulates during the clonal expansion phase. Interestingly, whereas FK506 low but detectable levels in preadipocytes. Its expression rapidly increases after hormonal induction of differentiaitself does not have any effect on clonal expansion and adipocyte differention, at high concentrations it reverses tion. It is easily detectable during the second day of 3T3-L1 adipocyte differentiation, and maximal levels of expresthe inhibitory effect of rapamycin, another immunosuppressant that shares intracellular receptors (FKBPs) with sion are attained in mature adipocytes (27, 38). Induction of PPAR-d appears to precede that of PPAR-g. Expression FK506 (305, 307) Regardless of its mechanism, inhibition of proliferation by rapamycin is accompanied by inhibi-of PPAR-d, however, is rather widespread. It is detected in a variety of tissues as well as in several cultured cell lines, tion of mitogen-activated serine-threonine S6 kinase, indicating that clonal expansion is necessary for subsequent including the CH310T1/2, 3T3-C2, and NIH 3T3 (7). A transient increase in the expression of C/EBP-b and C/EBP-d adipocyte differentiation of 3T3-L1 cells. This also suggests that a phosphorylation-dephosphorylation mecha-isoforms precedes the increase in PPAR-g expression (27, 167, 299) . The subsequent decrease of C/EBP-b and C/EBPnism may be involved during the clonal expansion period. Interestingly, a transient increase in levels of the phospha-d in early to mid stages of differentiation is concomitant with the induction of C/EBP-a mRNA. This increase in C/ tase inhibitor HA2 occurs during the clonal expansion phase. Constitutive expression of HA2 blocks differentia-EBP-a expression occurs slightly before the expression of adipocyte-specific genes (27, 153, 167). Another transcription only during the clonal expansion period but not during later stages of differentiation. Moreover, inhibition of tion factor induced very early during adipocyte differentiation is sterol regulatory element binding protein-1c (SREBPadipocyte differentiation by HA2 can be overcome by treatment with the phosphatase inhibitor vanadate, sug-1c)/adipocyte determination and differentiation factor 1 (ADD1), a bHLH-leucine zipper protein that is involved in gesting that a critical tyrosine dephosphorylation is necessary during clonal expansion (157) .
cholesterol metabolism (26) and may also participate in adipocyte gene expression (136, 137) . During adipocyte differentiation, cells convert from C. Early Changes in Gene Expression a fibroblastic to a spherical shape, and dramatic changes occur in cell morphology, cytoskeletal components, and the level and type of extracellular matrix (ECM) compoAlthough it is helpful to schematize the stages of adipocyte differentiation into a hierarchy of molecular nents. Many of the studies on the effect of cytoskeletal and ECM components in adipocyte differentiation predate events, an accurate chronology of the earliest steps in adipocyte differentiation has not been elucidated. Growth the characterization of adipocyte transcription factors. It is likely that these changes could influence the expression arrest and clonal expansion are accompanied by complex changes in the pattern of gene expression that can differ and action of PPARs and/or C/EBPs during adipocyte differentiation. Decrease in actin and tubulin expression is with the cell culture models and the specific differentiation protocols employed. Expression of lipoprotein lipase an early event in adipocyte differentiation that precedes overt changes in morphology and the expression of adipo-(LPL) mRNA has often been cited as an early sign of adipocyte differentiation (3, 47, 98, 123, 166) . Lipoprotein cyte-specific genes (255) . These changes in cell shape reflect a distinct process in differentiation and are not the lipase is secreted by mature adipocytes and plays a central role in controlling lipid accumulation (48, 86) . However, result of accumulated lipid stores. 3T3 preadipocytes can undergo biochemical and morphological differentiation LPL expression occurs spontaneously at confluence and is independent of the addition of agents required for adi-even in conditions when triglyceride accumulation is blocked by deprivation of biotin, a cofactor for fatty acid pocyte differentiation (8, 9, 277). This suggests that LPL expression may reflect the growth-arrest stage rather than synthesis (148), or by addition of lipolytic agents (258) . A switch in collagen gene expression is also an early event being an early differentiation step. It is also synthesized and secreted by other mesenchymal cell types including of adipocyte differentiation. The relative concentrations of fibroblast-expressed type I and type III procollagen cardiac muscle cells and macrophages (49, 267) . Because LPL expression is not adipocyte specific and it is indepen-mRNA decline by 80-90% during 3T3-L1 differentiation, and secretion of type IV collagen and entactin/nidogen coordinate activation of several of these genes, including aP2, GLUT4, SCD1, phosphenolpyruvate carboxykinase increases (13, 290). Expression of a 2 -collagen type VI mRNA is first detectable upon confluence in Ob1771 cells (PEPCK), and leptin (113, 162, 175, 269, 270) . The function of PPAR-g and C/EBP-a in adipocyte differentiation is preand rises sharply after confluence (51) . It reaches maximal levels 4 days postconfluence and gradually decreases to sented in section VII. Experiments with BALB/c 3T3 mesenchymal stem cells 50% of maximal levels during differentiation (51) . Increased production of soluble and cell-associated chon-indicate that cells that have progressed beyond a specific stage in the differentiation process are committed to subsedroitin sulfate proteoglycan-I (versican) has been reported during 3T3-L1 differentiation, and this may account quent terminal differentiation and can neither dedifferentiate nor reenter mitosis (287, 294) . However, recent evidence for the observed increase in culture medium viscosity (29). The amount of pericellular fibronectin, as well as indicates that the precise stage beyond which adipocytes can be considered terminally differentiated is not clearly cellular synthesis of fibronectin, decreases by four-to fivefold during differentiation of 3T3-F442A cells (10). Pre-defined. Partially differentiated human preadipocytes, evidenced by substantial cytoplasmic lipid accumulation, are adipocyte factor-1 (pref-1), a recently described preadipocyte protein with epidermal growth factor (EGF)-like re-still capable of cell division as assessed histologically and by flow cytometry (210) . The progressive dedifferentiation peats, discussed in section VIB, has been hypothesized to be involved in maintaining the preadipose phenotype of primary mature adipocytes followed by cell division has also been reported (262) . Tumor necrosis factor-a treat- (246) (247) (248) . A dramatic decrease in pref-1 expression accompanies adipocyte differentiation; it is abundant in pre-ment of mature TA1 or 3T3-L1 adipocytes or newly differentiated primary human adipocytes results in decreased exadipocytes and is not detectable in mature fat cells. It is the only known gene whose expression is completely pression of adipocyte markers and loss of lipid, with the development of morphological changes resulting in long, downregulated during adipocyte differentiation.
spindle-shaped cytoplasmic extensions (202, 273, 274) . These cells therefore come to resemble preadipocytes.
D. Late Events and Terminal Differentiation
However, recent evidence indicates that although TNF-atreated adipocytes and preadipocytes appear to share many similar morphological characteristics and gene expression During the terminal phase of differentiation, adipocytes in culture markedly increase de novo lipogenesis and patterns, they likely differ considerably. As described in section VIB, pref-1 expression is easily detected in preadipoacquire sensitivity to insulin. The activity, protein, and mRNA levels for enzymes involved in triacylglycerol metab-cytes and is absent from mature adipocytes; pref-1 levels are not restored by TNF-a of mature adipocytes. Pref-1 olism including ATP citrate lyase, malic enzyme, acetyl-CoA carboxylase, stearoyl-CoA desaturase (SCD1), glycerol-3-expression may reflect a fundamental difference between naive preadipocytes and those that result from TNF-a treatphosphate acyltransferase, glycerol-3-phosphate dehydrogenase, fatty acid synthase, and glyceraldehyde-3-phosphate ment (301). True reversion to a preadipose phenotype, if it takes place in vivo, could play a role regulating adipocyte dehydrogenase increase 10-to 100-fold (200, 256, 291) . Glucose transporters (80) , insulin receptor number, and insulin number and consequently adipose tissue mass. The molecular and cellular events occurring during this process warrant sensitivity increase. During adipocyte differentiation, there is a loss of b 1 -adrenergic receptors and an increase in the more detailed study. b 2 -and the b 3 -subtypes; this results in an increase in total adrenergic receptor number (69, 70, 101, 152). In addition VI. FACTORS THAT MODULATE ADIPOCYTE to increases in mRNAs for proteins directly related to lipid DIFFERENTIATION metabolism, adipocytes also synthesize other adipose tissue-specific products. These include the following: aP2, an adipocyte-specific fatty acid binding protein also identified
The growth and differentiation of animal cells are controlled by communication between individual cells or beas 422 (19, 256); FAT/CD36, a putative fatty acid transporter (125, 239) ; and perilipin, a lipid droplet-associated protein tween cells and the extracellular environment. Adipocyte differentiation therefore requires the cell to process a variety (94) . In addition, adipocytes produce a number of secreted products, discussed in section II. These include the follow-of combinatorial inputs during the decision to undergo differentiation. Hormones and growth factors with a role in ing: monobutyrin, an angiogenic agent; adipsin, a homolog of the serine protease complement factor D; Acrp30/Adi-adipocyte differentiation act via specific receptors to transduce external growth and differentiation signals through a poQ; PAI-1; and angiotensinogen II (5, 41, 61, 119, 127, 229). Leptin is also increased during in vitro terminal differentia-cascade of intracellular events. Identification of agents or molecules that modulate the process in either a positive or tion of adipocytes, although its level is much lower than that detected in adipose tissue (165) . Peroxisome proliferator negative manner provides insight into the signal transduction pathways involved. Extracellular matrix proteins may activated receptor-g and/or C/EBP-a is implicated in the IGF-I, insulin-like growth factor I; EGF, epidermal growth factor; TGF, transforming growth factor; FGF, fibroblast growth factor; PDGF, platelet-derived growth factor; IL-1, interleukin-1; TNF-a, tumor necrosis factor-a; PG, prostaglandin; TPA, 12-O-tetradecanoylphorbol 13-acetate.
play an important role in modulating adipocyte differentia-problems in comparing results obtained with different cell tion by permitting the morphological changes and adipocyte-culture models under various culture conditions. A role specific gene expression that accompany differentiation. for GH in adipocyte differentiation was first reported by The combination of hormones and growth/differentiation Green et al. (93) . Growth hormone has been shown to be factors that trigger or potentiate adipocyte differentiation necessary for differentiation of 3T3-F442A cells to adipohas been extensively examined and is summarized in Table cytes , and it has been suggested that GH promotes differ-2. All preadipose cell lines exhibit some degree of spontane-entiation and sensitizes the cells to the mitogenic effects ous conversion when grown in the presence of fetal calf of IGF-I for clonal expansion (46, 93, 102) . Sonenberg and serum, indicating serum is integral to the differentiation pro-co-workers (46, 102) suggested that GH may promote 3T3-cess. However, serum components are neither well charac-F442A adipose conversion by inducing an antimitogenic terized nor easily controllable. The development of chemi-state that is accompanied by decreased synthesis of the cally defined serum-free media suitable for the differentia-ECM proteins fibronectin and a-I collagen. The role of GH tion of preadipose cell lines and primary preadipocytes has is also recognized in studies employing Ob1771 preadipoaided the assessment of the precise hormonal requirements cytes; in serum-free medium, GH increases the extent of for differentiation. Although the full complement of inducing adipocyte differentiation (35). Growth hormone stimuagents required for differentiation varies with each cell cul-lates IGF-I gene transcription and, as discussed below, ture model, IGF-I, cAMP, and glucocorticoids are generally IGF-I is necessary for adipocyte differentiation. It has considered necessary for the induction of differentiation ei-been suggested that IGF-I secreted from Ob1771 cells ther in serum-containing or in serum-free media. In addition could act in an autocrine/paracrine fashion to induce difto stimulatory factors, agents that suppress the differentia-ferentiation of Ob1771 cells (133) . In contrast to observation of preadipocytes have also been identified. These may tions in preadipose cell lines, no stimulatory effect of GH act either by their mitogenic properties, as for various is observed in primary preadipocyte cultures. Initial regrowth factors, or by other independent mechanisms, as in ports on the effect of GH on rat and human preadipocytes the case of pref-1. Recent work has begun to clarify how indicate a lack of GH action (283). Because these studies these exogenous signals may influence transcription factors were performed under serum-containing conditions, the such as C/EBP and PPAR-g that are critical for activation effects of GH may not have been detectable. This concern of adipocyte genes and adipocyte differentiation.
was addressed in serum-free studies wherein GH was demonstrated to inhibit differentiation of rat, porcine, and human preadipocytes (81, 107, 283, 284) . Although GH A. Hormones and Signal Transduction Pathways markedly stimulates IGF-I production in rat preadipoRegulating Adipocyte Differentiation cytes, which in turn promoted cell proliferation, the antiadipogenic action of GH is not related to growth promo-
Growth hormone and IGF-I
tion mediated by IGF-I. Addition of an anti-IGF-I monoclonal antibody prevents the stimulatory effect on cell Studies addressing the role of growth hormone (GH) and IGF-I in adipocyte differentiation illustrate potential proliferation but not the reduction of differentiation (284). In addition to the known lipolytic activity of GH, inhibition preadipocytes, where downregulation of c-Ras before confluence abolishes their differentiation (209) . Recently, of adipocyte differentiation may explain the effect of GH on adipose tissue mass in vivo. The conflicting results for a serine/threonine kinase Akt (PKB) also has been demonstrated to be involved in adipocyte differentiation. Akt the action of GH on the differentiation of preadipose cell lines and primary preadipocyte cultures highlight a sub-is activated by insulin and certain growth factors, and evidence indicates it functions as a downstream effector stantial biological difference between these two models. Each may represent different stages of the adipocyte lin-of phosphatidylinositol 3-kinase pathway. Expression of constitutively active Akt in 3T3-L1 cells results in their eage; it has been proposed that the requirement for GH is obviated in primary cultures by their prior in vivo expo-spontaneous differentiation into adipocytes in the absence of the normal inducing agents dexamethasone/MIX/ sure to circulating GH. These cells may therefore be primed for subsequent sensitivity to other adipogenic insulin, suggesting the involvment of Akt-mediating signaling in adipocyte differentiation (142) . agents (2, 283).
A requirement of IGF-I or pharmacological concentrations of insulin in adipocyte differentiation has been 2. Other growth factors and cytokines clearly demonstrated. Rubin and colleagues first reported that IGF-I is an essential factor for 3T3-L1 adipocyte differUnlike IGF-I, other growth factors and cytokines are generally considered as inhibitors of adipocyte differentiaentiation, using fetal calf serum depleted of GH, insulin, and IGF-I by charcoal and ion-exchange resin treatment. tion. This is perhaps because of the their mitogenic effects, since cell growth and differentiation are usually Under both serum-containing and serum-free conditions, IGF-I has a dose-dependent action on 3T3-L1 preadipocyte mutually exclusive. As discussed in section VA, growth arrest is requisite for differentiation. Several studies indidifferentiation (230, 251) . Insulin-like growth factor-I also stimulates adipogenesis of primary rat, rabbit, and porcine cate a role for those growth factors that function through the EGF receptor, such as EGF and TGF-a, in adipose preadipocytes (57, 190, 211) , indicating that this growth factor may be an essential regulator of fat cell formation. tissue development. Transforming growth factor-a inhibits differentiation of 3T3-F442A and rat preadipocytes, and In addition to IGF-I, clonal and primary preadipocytes also secrete insulin-like growth factor binding proteins transgenic mice overexpressing TGF-a have a 50% reduction of total body fat (163, 233) . Epidermal growth factor (IGFBPs) in a differentiation-dependent manner, indicating that IGFBPs may be important in modulating IGF-I inhibits differentiation of mouse, rat, and human preadipocytes (105, 233, 282), and subcutaneous administration action in adipogenesis (22, 40, 190, 283) . The mechanisms of action of IGF-I/IGFBPs are not well understood, but of EGF to newborn rats results in a substantial decrease in fat pad weight, which suggests a delayed formation of they are most likely acting in an autocrine/paracrine manner.
adipocytes from preadipocytes (238). However, EGF is not always inhibitory. Differentiation of 3T3-L1 preadipoThe adipogenic effects of IGF-I indicate the involvement of a phosphorylation-dephosphorylation mecha-cytes grown in serum-free medium has been reported to depend on EGF or platelet-derived growth factor (PDGF) nism, subsequent to IGF-I receptor tyrosine phosphorylation, in intracellular signaling during adipocyte differentia- (230) . Chronic treatment of porcine preadipocyte cultures with EGF does not significantly alter their differentiation tion. Transfection of either normal or transforming alleles of H-Ras apparently bypasses the need for IGF-I or high (Gregoire et al., unpublished data).
The role of basic fibroblast growth factor (bFGF) concentrations of insulin in the 3T3-L1 system (17, 207). The observation that transfected Raf-1 oncogenes also and PDGF in adipocyte differentiation is not clear. Basic fibroblast growth factor has been shown to have antiadiinduce 3T3-L1 preadipocyte differentiation and that a dominant-negative Raf-1 blocks this process indicates that pogenic effects in several preadipocyte cell lines under serum-containing conditions (109, 184, 185), whereas it Raf proteins act downstream from Ras. However, transfection of Raf-1 induces only partial differentiation, indi-has no effect in serum-free conditions (230) . Moreover, in serum-free conditions, exposure of human preadipocating that Raf-independent pathways downstream of Ras may be involved in adipocyte differentiation. In this case, cytes to varying concentrations of bFGF has no effect on the number and morphology of differentiating cells (105) Raf-1-initiated signals did not activate the mitogen-activated protein kinase (MAPK) or RS kinase, suggesting and either a modest or no stimulatory effect on rat preadipocytes (236, 282). Platelet-derived growth factor also has a functional dissociation between Raf-1 and MAPK/RSK activation in Ras signaling pathways leading to 3T3-L1 been reported to either inhibit (109, 184) , have no effect (230) , or promote (16) differentiation of preadipose cell differentiation (208) . This agrees with the observation that MAPK activation is not required for the differentiation lines. In addition, despite the obvious mitogenic activity seen in human preadipocyte cultures, PDGF did not subprocess (71). The role of Ras as an integral component of the differentiation-promoting IGF-I signaling pathway stantially affect adipogenesis (105). Taken together, these reports suggest that the inhibitory effects of these growth was also recently demonstrated for C3H10T1/2-derived factors may depend on the origin, the state of develop-made, the variability of serum composition must be taken into account, since serum itself may provide various facment of the target preadipocytes, and culture conditions. In most cell culture models, TGF-b is a potent inhibitor tors. Dexamethasone, a synthetic glucocorticoid, is a component of the dexamethasone/MIX differentiation cocktail of adipocyte differentiation (160, 203, 237, 253, 282) . A possible mechanism for TGF-b inhibition of adipocyte dif-established for 3T3-L1 cells by Rubin et al. and dexamethasone is also routinely used for the differentiation of other ferentiation may be via increasing synthesis of ECM components. The ECM influences adipocyte differentiation, as preadipocyte cell lines (37, 78, 99, 224). It is also employed for the differentiation of primary preadipocytes derived discussed in section VIC, and TGF-b increases synthesis of ECM components (110) . Inhibition of in vitro adipocyte from different fat depots from various species, including rodents, rabbits, pigs, and humans (96, 104, 160, 213, 264) . differentiation, assessed by triglyceride accumulation and expression of various marker mRNAs, is also reported for Furthermore, dexamethasone is used for optimal adipocyte differentiation even in studies where transfection of PPARa number of cytokines. Interleukin-11 has a dose-dependent inhibitory effect for both 3T3-L1 differentiation and g and/or C/EBP-a was employed to induce adipocyte differentiation of fibroblasts (272, 300). The role of PPAR-g and for adipose conversion of bone marrow stroma-derived H-1/A cells. Inhibition is dominant over the effect of stan-C/EBP in adipocyte differentiation is discussed in detail in section VII. Depending on the origin of the cells and culture dard inducing agents (193, 194) . Interferon-g and interleukin-1b inhibit the adipoconversion of 3T3-derived preadi-conditions, glucocorticoid treatment is either required for differentiation or acts to only accelerate this process. In pocyte cell lines and primary rodent preadipocytes (95, 134, 199) . Tumor necrosis factor-a decreases LPL synthe-serum-free medium, differentiation of porcine, rabbit, and human preadipocytes appears strictly dependent on the sis and inhibits adipocyte differentiation. As mentioned in section VD, when applied to mature adipocytes at fairly addition of glucocorticoids (104, 213, 264) , whereas extensive differentiation of rat preadipocytes occurs in the abhigh doses for a long period, TNF-a has been shown to cause loss of intracytoplasmic lipids, wherein the cells sence of glucocorticoids (57, 97) . It has been demonstrated in 3T3-L1 cells that glucocorticoids induce expression of resemble a preadipocyte phenotype (273, 274). This TNFa-mediated reversal of adipocyte differentiation has been C/EBP-d. This increase may contribute to the formation of C/EBP-d-C/EBP-b heterodimers, which in turn may lead to shown to be associated with the downregulation of C/EBP-a and induction of c-myc expression (189, 259, PPAR-g expression (299) . In studies with Ob1771 preadipocytes, glucocorticoid effects have been shown to be medi-297). In addition, TNF-a treatment causes a rapid decrease in the levels of PPAR-g mRNA and protein, as well ated through increased metabolism of arachidonic acid leading to an increase in production of prostacyclin, which as a parallel decrease in PPAR-g DNA binding activity that precedes the decrease in C/EBP-a and aP2. This sug-in turn increases intracellular cAMP (4).
The ability of RA to affect various differentiation progests that the downregulation of PPAR-g may be a mechanism whereby TNF-a exerts its effects in the mature adi-cesses including the terminal events of the adipocyte differentiation program has been recognized for several years. pocyte (301, 311). Furthermore, it has been shown that PPAR-g is a phosphoprotein that undergoes EGF-stimu-When used at supraphysiological concentration, RA inhibits adipocyte differentiation of preadipocyte cell lines and prilated MEK and MAPK-dependent phosphorylation. This phosphorylated form is less active in transactivation of mary porcine preadipocytes (60, 263) . Retinoic acid addition either before or after treatment with inducing agents adipocyte genes and in promoting adipogenesis (1, 30, 118) . This therefore suggests that some of the growth does not affect differentiation, indicating that RA acts at an early stage in differentiation. This finding is supported by factors inhibitory to adipocyte differentiation might act through the MAPK pathway to phosphorylate PPAR-g. the observation that RA treatment prevents induction of C/ EBP-a and interferes with the mechanisms that induce as However, insulin treatment, which is known to increase lipid accumulation during adipocyte differentiation, also well as maintain PPAR-g expression. These actions of RA seem to be predominantly mediated by liganded RA recepresults in PPAR-g phosphorylation (311). Further studies are needed to address this apparent discrepancy.
tors (RARs) rather than retinoid X receptors (RXRs) (38, 302). Moreover, recent evidence indicates that the inhibitory effects of RA occur before PPAR-g expression by 3. Nuclear hormone superfamily blocking C/EBP-b induction (232) . In contrast to the inhibitory effects observed for supraphysiological concentration Members of the nuclear hormone superfamily, including glucocorticoids, 3,3,5-triiodothyronine (T 3 ), and RA, of RA, concentrations close to the receptor dissociation constant act as potent adipogenic inducers for Ob17 cells influence adipocyte differentiation. Their action in adipocyte differentiation is not well characterized at the molecu-and rat preadipocytes; this specifically involves the RARa subtype (225, 226) . A critical role of RA in adipocyte lar level, but these hormones in general exert nuclear effects by binding to their respective intracellular hormone differentiation has been recently highlighted by the finding that pretreatment of differentiating ES cell-derived emreceptors. Although some general conclusions can be bryoid bodies with RA for a short period of time results in mRNA expression and production of TGF-a, both in undifferentiated and differentiated cells. Both PGF 2a and TGF-a, a high degree of adipogenesis. In this case, the role of RA in these very early events of the adipocyte differentiation which are inhibitors of adipocyte differentiation, are produced locally in adipose tissue. Therefore, stimulation of program can be distinguished from that of RA on terminal differentiation described above, since neither adipogenic TGF-a expression by PGF 2a could represent an amplification mechanism to modulate preadipocyte differentiation hormones nor potent activators of PPARs could substitute for RA (52) . and adipocyte function within adipose tissue (156). In contrast to the inhibitory role of PGF 2a , a potent and 3,3,5-Triiodothyronine also has been implicated in the terminal differentiation of Ob17 preadipocytes (82). specific adipogenic role has been attributed to prostacyclin (PGI 2 ). This prostanoid is one of the major metaboThe role of T 3 appears to be restricted to the Ob17 preadipose cell line, since no clear requirement for T 3 is ob-lites of arachidonic acid both in preadipose and adipose cells, and it has been previously described as an autocrine/ served in other preadipocyte culture models, including the 3T3-L1 and rat, porcine, or human primary preadipocyte paracrine adipogenic effector for Ob1771 preadipose cells and primary rodent and human preadipocytes (35, 186, cultures (57, 103, 104, 230, 236, 264, 293) . 282). Carbacyclin, a stable prostacyclin analog, has been shown to act by means of two intracellular signaling path-4. Prostaglandins ways known to synergize in inducing adipocyte differentiation, i.e., concomitant elevation of cAMP and free intraSeveral lines of evidence indicate that arachidonate metabolites may play an important physiological role in cellular calcium (280, 281). Prostacyclin has also been reported to be an activator of the three known mammalian adipose tissue metabolism and development. Mature adipocytes and cultured preadipocytes produce significant PPARs (a, d, and g) and to be the most effective activator for PPAR-d described to date. This suggests that in addiamounts of prostaglandins (PGs), including PGF 2a , PGE 2 , PGD 2 , and PGI 2 (122, 215). Prostaglandin E 2 is a strong tion to the biological effects of prostacyclin mediated by its cell-surface receptor, its ability to promote differentiaantilipolytic compound, and PGF 2a and PGI 2 have been shown to modulate preadipocyte differentiation. Prosta-tion may also be mediated by PPARs (15, 28, 111). The paracrine adipogenic effect of PGI 2 has also been reported glandin D 2 and its 15-deoxy-J 2 derivative may be endogenous ligands for PPAR-g and therefore act as adipogenic to be controlled by angiotensin II. This effect is mediated through the AT 2 subtype of the angiotensin II receptor. signals (141) . As presented in section VII, treatment with synthetic PPAR-g agonists stimulates adipose conversion Ob1771 adipose cells challenged with this vasoactive peptide produce PGI 2 . Prostacyclin released by differentiated of 3T3-L1 preadipocytes (27).
Prostaglandin F 2a inhibits differentiation of various Ob1771 cells is able to induce preadipose cells to differentiate into adipose cells (53) . In vivo, this paracrine mode preadipose cell lines and primary rat preadipocytes (122, 174, 188, 216, 235, 282). Prostanoid FP receptor agonists of action may represent a crucial biological signal in the hyperplastic development of adipose tissue known to ochave been recently reported to be potent inhibitors of differentiation for 3T3-L1 cells and primary rat preadipo-cur once adipose cells reach their maximal size. The role of PGE 2 and PGD 2 in adipocyte differentiation is less cytes, confirming the involvement of a FP prostanoid receptor in the inhibition of adipocyte differentiation (34, clear. Depending on the cell culture model systems, they have been reported to either inhibit or have no effect on 234). In 3T3-L1 cells, FP receptor stimulation causes a transient increase in intracellular calcium, activation of a preadipocyte differentiation (34, 235). calcium/calmodulin-dependent protein kinase (CaM kinase), and an increase in DNA synthesis that is associated 5. cAMP, G proteins, and protein kinase C with the inhibition of differentiation. The addition to differentiating cells of KN-62, a CaM kinase inhibitor, in the Methylisobutylxanthine accelerates the differentiation of preadipose cell lines and primary preadipocytes. presence of the FP receptor agonist reverses the inhibition of differentiation and suggests a critical role for a As with glucocorticoids, MIX is routinely used for the differentiation of a variety of preadipocytes. MethylisobuCaM kinase in adipocyte differentiation (174) . However, the precise role of CaM kinases in this process remains tylxanthine has been shown to increase expression of C/EBP-b, and this increase is required for subsequent to be clarified, since temporal activation of CaM kinase type II has been recently reported to be an obligatory PPAR-g expression and adipocyte differentiation. The role of C/EBP-b in adipogenesis is presented in detail in step for adipogenesis. Blockage of CaM kinase type II activation with either KN-62 or KN-93 prevents the conver-section VII. The precise mode of action of MIX is not resolved. Methylisobutylxanthine is known to inhibit sion of 3T3-L1 fibroblasts to adipocytes. This effect was dependent on the timing of inhibitor addition (285 184, 240, 242) . Therefore, compared with epididymal preadipocytes, the higher capacity creasing cAMP accumulation. However, contradictory results have been obtained in studies that address whether of subcutaneous preadipocytes to differentiate into adipocytes seems to correlate with a decrease in G q a expresthe cAMP elevating agents dibutyryl cAMP or forskolin can replace the effects of MIX in stimulating adipocyte sion and a decrease in G q a-mediated PKC activation (56) .
Although the negative effect of PKC activation on differentiation (243, 293, 296, 304) . In studies on 3T3-F442A preadipocytes, modulation of adipogenesis by adipocyte differentiation appears well established, the role played by the different PKC isoforms in this process cAMP has been reported to depend on the increase in intracellular cAMP levels achieved by forskolin treatment; remains unsettled. Protein kinase C is a family containing at least 11 isoforms divided into three major groups based forskolin concentrations in the nanomolar range promote differentiation, whereas concentrations above the micro-on their structure and mode of activation (55) . Several PKC isoforms are expressed in mature isolated rodent molar range inhibit the differentiation process (304).
The G proteins G s a and G i a have been shown to adipocytes as well as in 3T3-L1 preadipocytes and adipocytes. Differentiation-dependent changes in isoform exmediate adipocyte differentiation in 3T3-L1 cells in a manner apparently independent of adenylyl cyclase (87, 288) . pression occur during adipogenesis (66, 74, 149, 171) . Although total PKC activity is reduced during 3T3-L1 differAntisense oligodeoxynucleotides to G s a accelerate adipocyte differentiation, and agents that activate G s a block entiation, not all isoforms have lowered expression.
Protein kinase C-e expression occurs only with differentidifferentiation. Likewise, expression of the inhibitory subunit Ga i-2 promotes lipid accumulation. These effects of ation, and upregulation of this isoform does not occur in cells treated with the inhibitory agent TNF-a. During TNF-G s a and Ga i-2 are exerted at ambient or elevated intracellular cAMP levels, demonstrating that this critical role of a-induced inhibition of adipocyte differentiation, downregulation of the PKC-a isoform was blocked; this sug-G proteins in adipocyte differentiation is independent of adenylyl cyclase (288) . Constitutive expression of Ga i-2 gests that downregulation of PKC-a is a discrete step in the 3T3-L1 differentiation program (171) . Protein kinase and G s a chimeras has been used in 3T3-L1 cells to define the specific regions of these proteins responsible for re-C-a and PKC-z also decrease during rat preadipocyte differentiation, and the possible involvement of PKC-z in the pression of adipogenesis. The domain of G s a requisite for regulation of adipogenesis maps to a region that includes postreceptor signaling pathway of insulin is suggested by studies in these primary cultures (149) . Ectopic expresswitch domains I and II. These have been found to be spatially distinct from the domains that regulate adenylyl sion of PKC-h is also reported to alter the expression of cyclins and cdk inhibitors and induce adipogenesis in NIH cyclase; this is consistent with the inability of cAMP to influence the adipocyte differentiation process (286) . A 3T3 fibroblasts (161). These findings indicate that the PKC pathway of signal transduction is part of a highly complex potential role for the G protein G q a in the control of adipose tissue physiology and/or preadipocyte differentiation system that likely exerts negative as well as positive effects on the adipocyte differentiation process. has been recently reported. Ablation of G q a by antisense RNA under the control of PEPCK promoter, which directs expression to WAT and liver in transgenic mice, causes B. Pref-1, an EGF Repeat-Containing Inhibitor of increased body mass and hyperadiposity that persists Adipocyte Differentiation through adult life (79). Absence of G q a abolishes the A 1 adrenergic regulation of lipolysis, apparently predisposing the mice to fat accumulation. However, because the basis Comparison of the genes that are regulated by the adipogenic inducing agents dexamethasone/MIX in 3T3-for hyperadiposity in these G q a-deficient mice remains to be established, G q a may also control adipogenic conver-L1 cells and the closely related but differentiationdefective 3T3-C2 cells has resulted in the identification of sion in vivo (79). Rat primary subcutaneous preadipocytes in culture display a higher capacity to differentiate than preadipocyte factor-1 (pref-1). 3T3-C2 cells, which do not undergo differentiation in response to the adipogenic inepididymal preadipocytes (97) . This site specificity of differentiation capacity was recently shown to be related at ducing agents dexamethasone/MIX, express approximately threefold higher pref-1 levels than 3T3-L1 preadileast in part to the differences in G q a subunit expression (56) . During adipogenesis, no major site differences are pocytes. Recent evidence has demonstrated that pref-1 is a EGF repeat-containing transmembrane protein that found in the amount of G s a and G i a subunits. However, G q a dramatically decreases in subcutaneous-derived cells inhibits adipocyte differentiation and suggests that this molecule may link adipocyte differentiation signals from while it remains constant in epididymal-derived cells. The G q a subunit mediates phospholipase C-b activation lead-the extracellular environment to the cell interior (246) (247) (248) 250) . Expression of pref-1 in 3T3-L1 preadipocytes ing to diacylglycerol formation and protein kinase C (PKC) activation (65) , an event known to downregulate decreases to undetectable levels during their differentiation to mature adipocytes. Fetal calf serum, an essential adipoconversion of preadipose cell lines as well as rat However, conditioned media from pref-1-transfected COS pocyte factor-1 does not appear to have the mitogenic effects (C. Li, C. M. Smas, and H. S. Sul, unpublished data) cells drastically reduce adipocyte differentiation in response to dexamethasone/MIX treatment. These data, and normally associated with the inhibitory actions of growth factors and cytokines described in section VIA2. This sug-the fact that pref-1 antibody blocks the inhibitory action of soluble pref-1, suggest a specific inhibitory effect of gests that pref-1 may function via a unique mechanism to inhibit adipocyte differentiation.
pref-1 in adipocyte differentiation and are consistent with the existence of a specific pref-1 receptor. These findings indicate that, although synthesized as a transmembrane
Inhibitory action in adipogenesis
molecule, the pref-1 ectodomain alone is sufficient for its inhibitory effects. The inhibitory action of pref-1 on adipocyte differentiation has been demonstrated by two approaches: 1) interfering with the normal downregulation of pref-1 that 2. Generation of soluble pref-1 occurs during adipocyte differentiation by constitutive expression of pref-1 in 3T3-L1 preadipocytes, and 2) addition
The inhibitory actions of the pref-1 ectodomain indicate that the cytoplasmic tail is not required for the prefof a soluble form of the pref-1 ectodomain to culture media during and after the dexamethasone/MIX differentia-1 adipo-inhibitory function, although this region may have
an as yet unidentified function. Processing of transmemtion treatment. To determine the effect of persistent pref-1 expression on adipocyte differentiation, two independent brane precursors to generate active factors has been shown for a variety of molecules. For example, all soluble pools of several hundred clones transfected with the pref-1 expression construct have been examined for their ability factors that function through the EGF receptor derive from cleavage of transmembrane precursors, as does the to differentiate in response to the adipogenic agents dexamethasone/MIX. Although a high degree of differentiation kit ligand. Transfection studies in COS cells reveal that processing of transmembrane pref-1 occurs at two sites is observed in controls of nontransfected 3T3-L1 preadipocytes or stable pools of 3T3-L1 harboring the reverse ori-in the extracellular domain. In addition to full-length transmembrane pref-1, a cell-associated protein of 25 kDa entation of the pref-1 cDNA, differentiation is drastically reduced in the pref-1-transfected cultures. These cultures has been identified through addition of a myc epitope tag to the extreme COOH terminus of pref-1 (246) . This 25-maintain fibroblast morphology and contain few fat cells. Oil Red O staining reveals little to no lipid accumulation kDa protein is predicted to correspond to a residual membrane portion of full-length pref-1 after a cleavage in the and markedly lower expression of aP2 and SCD1 mRNAs. Examination of the cultures by light microscopy reveals extracellular domain. Pulse-chase analysis of the media of pref-1-transfected COS cells indicates that the major that the decrease in lipid staining in the pref-1-transfected cells is because of a decrease in the total number of cells soluble form of pref-1 is 50 kDa and the existence of 31-and 24-to 25-kDa soluble pref-1 proteins. The time course that differentiate to adipocytes, not to a generally lower amount of lipid per cell (248) .
of disappearance of cell-associated and increase in soluble pref-1 is consistent with a precursor-product relationThe inhibitory effects of the pref-1 ectodomain have been shown by addition of soluble pref-1-glutathione-S-ship. Addition of a consensus phosphorylation site for Akinase to the second EGF repeat of the pref-1 extracellular transferase (GST) fusion protein to 3T3-L1 preadipocytes during the differentiation period. In the presence of solu-domain, and subsequent phosphorylation, has determined that the 50-kDa and 24-to 25-kDa soluble forms contain ble pref-1, only 10% of cells undergo adipocyte differentiation in response to the dexamethasone/MIX treatment, in the second EGF repeat and likely derive from the NH 2 terminus of the ectodomain. The 31-kDa soluble pref-1 is comparison with the high degree of differentiation in GSTtreated and untreated control cultures. The levels of not phosphorylated by these means, and its origins are unclear. Taken together, these predict two processing mRNA for fatty acid synthase, SCD1, and aP2 in the pref-1-treated cells are 20% that of GST-treated or untreated events: a membrane-proximal cleavage to generate the 50-kDa soluble pref-1 and a membrane-distal cleavage that controls. Moreover, C/EBP-a and PPAR-g mRNAs are similarly decreased. The inability of 3T3-L1 cells to express may generate the smaller soluble forms. These observations and the fact that the complete ectodomain acts to adipocyte transcription factors in the presence of soluble pref-1 suggests that its inhibitory effects are exerted early inhibit adipocyte differentiation indicate that generation of soluble pref-1 from a transmembrane precursor exin differentiation. The inhibitory effects of soluble pref-1 are confirmed by experiments wherein 3T3-L1 preadipo-tends the inhibitory range of action of the molecule. (192, 219, 220, 292) . Although the mechanism of pref-1 inhibition of adipocyte differentiation Analysis of the soluble products that are generated remains to be determined, given the importance of cell from not only full-length pref-1, as above, but by three shape modulation and the ECM environment in adipocyte additional alternately spliced pref-1 forms indicate that differentiation, discussed in section VIC, transmembrane the generation of the 50-kDa soluble pref-1 is dependent pref-1 may possibly function by the interaction of its EGFon the alternate pref-1 transcript expressed. Whereas each like domains with EGF-like or other protein domains presof the four alternately spliced forms of pref-1 resulted in ent in ECM molecules, thereby maintaining the preadipose production of the smaller soluble forms, only the two phenotype. These could include versican and laminin; both longest of the alternately spliced pref-1 cDNAs generate contain EGF-repeat domains and are modulated during adithe largest soluble form. This indicates that the spliced-pocyte differentiation. Additionally, transmembrane and/or out sequence includes a processing site and localizes the soluble pref-1 may act as a ligand for an as yet unidentified cleavage to within a 22-amino acid juxtamembrane se-preadipocyte receptor molecule, to maintain signal transquence. It therefore appears that the mode of pref-1 func-duction pathways inhibitory to adipogenesis. Identification tion, juxtacrine or paracrine, depends on the specific alter-of proteins that interact with pref-1 will lend valuable innate pref-1 transcript expressed. However, the fact that sights into the mechanisms of pref-1 action and will elucithe pref-1 ectodomain alone inhibits adipocyte differentia-date how the inhibitory signals of pref-1 are balanced tion indicates generation of the inhibitory signal does not against the differentiation-promoting effects of PPAR-g and require the pref-1 cytoplasmic region. This suggests that C/EBP. the pref-1 molecule, in either transmembrane or soluble form, probably functions as a ligand to initiate/maintain C. Extracellular Matrix Components signals inhibitory to adipogenesis. It is highly unlikely pref-1 acts through the EGF receptor. The spacing and conservation of amino acids that are required for EGFLinks between exogenous hormones and transcripreceptor interaction are absent in pref-1. Preadipocyte tional regulators have begun to emerge, thereby allowing factor-1 does not affect DNA synthesis (Li et al., unpub-some integration of these two aspects in our understanding lished data) and therefore lacks the mitogenic activity that of the control of adipocyte differentiation. In contrast, is normally associated with EGF receptor function.
knowledge of the molecular mechanisms regarding the efThe role of EGF repeats in other molecules leads to fect of the ECM on adipocyte differentiation is lacking. several hypotheses for pref-1 action in adipocyte differentia-These studies are particularly crucial if we are to fully untion. The EGF repeat unit is a 35-to 40-amino acid sequence derstand the process in tissues, where differentiation occharacterized by highly conserved spacing of six cysteine curs in close association with the stromal-vascular cell popresidues that form three disulfide bonds. Members of the ulation. Cell adhesion molecules and ECM components EGF-repeat family of proteins are membrane-bound or se-modulate the interaction of cells with their environment in creted proteins that act on cell growth and differentiation a manner that influences cell differentiation and migration. in an astonishing array of biological settings (12, 154, 192) . This may lead to cytoskeletal network rearrangement and A single EGF-like domain is the functional unit of EGF, an intracellular cascade of signal transduction that influ-TGF-a, and other growth factors that interact with the EGF ences differentiation. Additionally, a physical connection receptor (33). The EGF-repeat family also includes proteins between the ECM and nuclear matrix, via the cytoskeleton, of the blood-clotting cascade, the LDL receptor, and several has been proposed (129) . The ECM, through altering cell multidomain ECM proteins and cell adhesion molecules spreading, may expose the cell surface to various growth with a demonstrated role in cell guidance and development. factors present in the environment (181) , and ECM compoStrong evidence for the role of EGF-repeat molecules in the nents have been demonstrated to bind and sequester growth regulation of differentiation and development is provided by factors (303) . The effect of ECM components on cell differthe function of the transmembrane protein Notch and its entiation is demonstrated in general by the fact that a deligands Delta and Serrate in Drosophila. Although the exact crease in tissue-specific markers often occurs upon plating molecular mechanism remains to be elucidated, the ligand-of primary cells onto tissue-culture dishes. Interaction beNotch extracellular domain interaction brings about the as-tween cell-matrix and nuclear events has been evidenced by sociation of the intracellular domain of Notch with Su(H), numerous studies including b-casein induction by basement transcriptional activation of specific genes, and subsequent membrane substratum of mammary epithelial cells (261) , cell fate determination (14, 144). The identification and basement membrane inhibition of keratinocyte differentiacharacterization of vertebrate notch homologs indicate sig-tion (88), transactivation of the cytotactin/tenascin and neunaling via EGF-repeat domains will likely be an important ral cell adhesion molecule (N-CAM) promoters by specific mechanism in mammalian cell lineage decision, as indicated homeodomain proteins (128) , and modulation of N-CAM in dissociated versus aggregated p19 embryonal cells (170) . by the effects of Notch in muscle differentiation and T-How the ECM influences adipocyte differentiation is yet to portion of differentiation-defective 3T3-C2 cells undergo morphological and biochemical conversion to adipocytes be addressed in appropriate molecular detail.
The ECM of adipose tissue interconnects adipocytes (197). Addition of soluble fibronectin and growth on fibronectin matrices markedly decreases differentiation of STand gives rise to fat cell clusters in vitro and to fat lobules of adipose tissue in vivo. During adipocyte differentiation, 13 preadipocytes. This is reversed by an antibody against the a 5 ,b 1 -integrin and by a short peptide corresponding to drastic changes occur in cell morphology, cytoskeletal components, and the level and type of ECM components the cell attachment domain of fibronectin. Interestingly, differentiation of these cells, on the other hand, is stimulated secreted as described in section VC. An early ultrastructural change seen in in vivo adipocyte differentiation is by the addition of a thermolysin digest of fibronectin (76).
The adipocyte-stimulating activity is in the NH 2 -terminal the deposition of collagen at the cell-ECM border and extracellular basement membrane biogenesis (183). Fi-fibrin binding domain and can be activated by use of specific matrix metalloproteinases (76, 77). These experiments sugbroblasts in developing fat tissue have loose interactions with the ECM that may be necessary for the morphologi-gest that fibronectin has the ability to both inhibit and stimulate adipocyte differentiation, depending on the state of the cal changes that accompany differentiation or to keep cells in close proximity and thereby increase their expo-molecule.
As described in section VC, changes in expression of sure to juxtacrine differentiation signals. Electron microscopy reveals that preadipose 3T3-F442A cells have limited specific types of collagen accompany adipocyte differentiation. Use of ethyl-3,4-dihydroxybenzoate (EDHB), a spegranular ECM deposits. In contrast, 3T3-F442A adipocytes appear interconnected by abundant ECM rods and fibers cific inhibitor of active collagen synthesis, highlights the role of collagen in modulating adipocyte differentiation. and resemble the fat cell clusters seen in lobules of adipose tissue (146). These changes may be related to the Exposure of TA1 cells to EDHB preceding confluence and during the initial stage of differentiation prevents cells loose interaction of the basement membrane with adipose cells that has been observed in fat tissue. Many of the from entering the terminal differentiation program; this demonstrates that differentiation of preadipose cells into ECM components, for example, laminin and entactin/nidogen, are known to interact with each other and the cell adipocytes requires active synthesis of collagen (124) . A role for proteoglycans in adipocyte differentiation is sugsurface. Modulation of ECM components could permit release of cell-cell adhesion and remodeling of cell com-gested by the observation that proteoglycan metabolism is altered during 3T3-L1 preadipocyte differentiation (29, ponents. These changes might be necessary for cellular reorganization and could provide a permissive or instruc-182). Levels of versican/CSGP-I, a chondroitin 4-sulfate proteoglycan, are increased early during 3T3-L1 cell differtive environment for the expression of adipocyte genes.
Subjecting preadipocytes to differentiation conditions entiation. This increase appears to correlate with the increased viscosity of the culture medium that occurs durin the presence of ECM components demonstrates their influence on adipocyte differentiation. Type I and III colla-ing differentiation. The role of ECM in the differentiation process is confirmed in primary preadipocyte studies gen, fibronectin, and poly-L-lysine, as well as b-integrins are negatively correlated with the differentiation of preadipo-(108, 214, 215, 279) . The source or type of ECM dictates the influence of ECM substrata on primary porcine preadicyte cell lines (11, 24, 221, 257, 290) , whereas increases in type IV collagen, entactin, and an unorthodox laminin pocyte differentiation (108). Laminin, in particular, may play a critical role in morphological changes of porcine complex accompany the adipocyte differentiation process (13, 195) . Culture of 3T3-F442A preadipocytes on fibronec-preadipocyte development. All of the above studies clearly indicate that ECM components modulate adipotin matrices decreases gene expression of lipogenic enzymes and leads to decreased triglyceride accumulation cyte differentiation, perhaps by release of cell-cell adhesion, thereby permitting changes in cell morphology or (257) , possibly by interfering with the cytoskeletal and morphological changes necessary for adipocyte differentiation. volume (29). It remains to be determined whether ECM components could be directly involved in initiating or The inhibitory effect of fibronectin is not observed by its addition to culture media, and this inhibition is overcome transducing signals for adipose differentiation or merely allow cells differential access to the growth and/or inhibiby keeping cells in a rounded configuration. These observations indicate that the inhibitory effect of fibronectin re-tory factors present in the surrounding environment. quires cell spreading. Cytochalasin D, an agent that disrupts actin filaments, overcomes the inhibitory effects of fibro-VII. TRANSCRIPTION FACTORS CRITICAL FOR nectin (257) , further indicating that cytoskeletal rearrange-ADIPOCYTE DIFFERENTIATION ment is a prerequisite for terminal differentiation. In a separate study, differentiation of 3T3- adipocyte-specific gene expression resulting in the mature process remains unclear. Retinoic acid but not potent PPAR activators can commit ES cells into the adipocyte lineage, adipocyte that is highly specialized for energy storage and homeostasis. As presented above, many classes of mole-suggesting that RAR may be involved in the initial steps of adipose cell development (52) . cules transduce inductive and inhibitory signals from the environment. Although the full complement of proteins
The role of other PPAR isoforms in adipogenesis remains to be resolved. Peroxisome proliferator-activated involved in this process remains to be determined, ultimately the PPAR and C/EBP family of transcription fac-receptor-a was also reported to be able to induce significant adipocyte differentiation in response to strong PPAR tors must function cooperatively to transactivate adipocyte genes and thereby bring about adipocyte differentia-activators. Because this isoform is only weakly expressed in adipocytes and has been reported to be less adipogenic tion. The role of transcription factors of the PPAR and C/EBP families in adipocyte differentiation has been ex-than PPAR-g, its precise role in triggering and/or maintaining the adipocyte phenotype remains unclear (28). Altensively reviewed recently (27, 153, 167) , and we present an overview only.
though PPAR-d is not adipocyte specific, this PPAR isoform is highly expressed in adipose tissue. It is upregulated very early during adipocyte differentiation and has A. PPAR Family been suggested to play an important role in adipogenesis Members of the C/EBP family were the first transcription factors demonstrated to play a major role in adipoincrease insulin sensitivity, can directly bind and activate PPAR-g and have been shown to stimulate adipose conver-cyte differentiation. These transcription factors have a basic transcriptional activation domain and an adjoining sion (140, 155, 227) . Thiazolidinediones are strongly adipogenic for fibroblasts and myoblasts, especially for those leucine zipper motif, which provides the ability for homoand heterodimerization. Isoforms of C/EBP are expressed expressing PPAR-g, with 15-deoxy-D-PGJ 2 , the most potent activator (72, 141). Whether 15-deoxy-D-PGJ 2 is the major in tissues, such as liver, that metabolize lipid and cholesterol-related compounds at high rates (43). Studies of adiendogenous ligand for PPAR-g is not yet known (27). The observations reporting that PPAR-g is highly expressed in pocyte differentiation, primarily in 3T3-L1 cells, provide extensive evidence for C/EPB-a function in adipocyte difadipocytes and that its ectopic expression is capable of triggering the entire program of adipogenesis in fibroblast ferentiation (27, 153, 166, 167) . Although not strictly adipocyte specific, C/EPB-a is expressed just before the tranand muscle cells has led to the hypothesis that PPAR-g can regulate development of the adipocyte lineage (272). scription of most adipocyte-specific genes is initiated.
CCAAT/enhancer binding protein-a binds and transactiAlthough PPAR-g plays a critical role in the induction and maintenance of the fully differentiated adipocyte pheno-vates the promoters of several adipocyte genes, including aP2, SCD1, GLUT-4, PEPCK, leptin, and the insulin receptype, its participation in the adipocyte lineage determination tor. Mutation of the C/EPB-a site in these genes abolishes of onset of adipocyte differentiation resulting from C/EBP-b action. Taken together, current data suggest that transactivation (121, 132, 172, 223) . In some instances, constitutive expression of C/EPB-a is sufficient to induce an increase in C/EBP-b above a threshold level induces expression of PPAR-g. Upon ligand activation, PPAR-g, differentiation of 3T3-L1 cells in the absence of hormonal agents, and expression of antisense C/EPB-a mRNA in in concert with C/EBP-a, leads to the full adipocyte differentiation program. 3T3-L1 preadipocytes prevents differentiation (158, 159). Moreover, C/EPB-a can efficiently promote adipogenesis
The observation that in 3T3-L1 preadipocytes C/EBP-b and C/EBP-d levels are increased by MIX and dexamethain a variety of mouse fibroblastic cells, including those that have little or no spontaneous capacity to develop into sone, respectively (32, 306), has led to the suggestion that C/EBP-b and C/EBP-d might relay the adipogenic effects adipocytes (75). In view of its known antimitotic activity, C/EPB-a has also been indicated to function in the termi-of these agents early in adipocyte differentiation. Expression of ectopic C/EBP-b in NIH 3T3 cells obviates the MIX nation of the mitotic clonal expansion that occurs early in the differentiation program and seems to be involved requirement for their differentiation, indicating that C/ EBP-b may be a primary effector of MIX action in adipoin the maintenance of the adipocyte phenotype through autoactivation of the C/EBP-a gene (42). Together, these cyte differentiation. The observed induction of C/EBP-d by dexamethasone could lead to the formation of C/EBPfindings provide evidence that C/EPB-a is both required and sufficient to induce adipocyte differentiation. Genera-d-C/EBP-b heterodimers, and these were postulated to be more transcriptionally active than C/EBP-b homodimers. tion of C/EPB-a knockout mice supports the physiological role of C/EPB-a in adipose tissue development, since C/ However, examination during the initial stages of differentiation of dexamethasone-treated NIH 3T3 fibroblasts that EBP-a null mice fail to develop WAT (289) . However, this study probably addresses the role of C/EPB-a in adipocyte ectopically express C/EBP-b indicates that C/EBP-d only minimally contributes to functional C/EBP complexes maturation rather than its potential function in the initiation and/or commitment of mesenchymal precursors. Al- (299) . Moreover, dexamethasone remains an absolute requirement for adipocyte differentiation of NIH 3T3 fibrothough mature white adipocytes are absent in C/EPB-a (0/0) mice, the presence of committed preadipocytes al-blasts ectopically expressing high levels of both C/EBP-d and C/EBP-b, indicating that C/EBP-d cannot substitute ready expressing early markers of differentiation has not been assessed, and their existence cannot be excluded. for the role of dexamethasone in the differentiation process (299). Fine-tuning of the control of adipocyte gene expression by C/EBP proteins involves homo-and heterodimerization C/EBP homologous protein-10 (CHOP-10) is an another member of the C/EBP family. It displays overall between the C/EBP-a, C/EBP-b, and C/EBP-d isoforms. Each isoform has a distinct temporal and spatial expres-sequence similarity to C/EBP proteins in the DNA binding and dimerization domain. However, the basic region of sion pattern during adipocyte differentiation (32). Whereas C/EBP-a expression occurs relatively late in dif-CHOP-10 deviates considerably in sequence from that of other C/EBP proteins, and CHOP-10-C/EBP heterodimers ferentiation, the b-and d-isoforms of C/EBP are present in preadipocytes, and their levels increase transiently are unable to bind to a common class of C/EBP sites. With respect to such sites, CHOP-10 appears to function as a early in differentiation. By late differentiation, C/EBP-b decreases to 50% of its initial level, and C/EBP-d is nearly negative modulator of the activity of C/EBP transcription factors (275). CHOP-10 is absent under normal conditions undetectable (32). Neither C/EBP-a, -b, nor -d is adipocyte specific (20, 32), although C/EBP-a is expressed at high and is induced by cellular stresses; its function under normal circumstances is still unclear. levels in the mature adipocyte and adipose tissue (32, 306) . CCAAT/enhancer binding protein-b and possibly C/EBP-d seem to function early as transcriptional activa-C. bHLH Family tors in the sequence of events leading to adipocyte differentiation. Conditions that cause expression of either the b-or d-isoforms accelerate adipogenesis in 3T3-L1 preadi-A potential role of bHLH in activating the adipocyte differentiation program has recently been suggested by pocytes (167) . Ectopic expression of C/EBP-b, particularly the liver-enriched transcriptional activator protein the observation that overexpression of Id3 prevents adipocyte differentiation (177) . Ids are a group of ubiquitous spliced form, activates the expression of PPAR-g in NIH 3T3 fibroblasts exposed to dexamethasone, insulin, and nuclear proteins that possess the helix-loop-helix domain but are missing the basic DNA binding domain. Ids are fetal bovine serum and stimulates their conversion into committed preadipocytes (300). Expression of PPAR-g is believed to block muscle differentiation by competing with myogenic bHLH proteins for dimerization with their induced by coexpression of C/EBP-b and C/EBP-d. Although this suggests that these two C/EBP isoforms may bHLH binding partner, E12/E47, which binds to an E-box motif to transactivate muscle-specific genes (126) . In 3T3-heterodimerize to directly regulate PPAR-g (299) , the increased PPAR-g expression may also be the indirect effect F442A cells as well as in primary preadipocyte cultures, level. A variety of agents influence adipocyte differentia-SREBP-1c/ADD1 displays a dual DNA specificity, binding tion, although their effects are somewhat dependent on to both an E-box motif and non-E-box motif (SRE-1) (137) .
the preadipose cell culture models and culture conditions A role in adipocyte differentiation is suggested by the employed. With this variability in mind, a general picture early increase of its mRNA levels during adipocyte differemerges, suggesting that the multitude of diverse regulaentiation and by its transactivation of several key lipotory signals likely converges at a few classic signal transgenic genes (64, 136) . SREBP-1c/ADD1 has been shown duction pathways. We can just now begin to connect the to increase fatty acid and fat synthesis, and this has been dots from hormonal and growth factor signals to specific attributed in part to its proposed influence on PPAR-g nuclear events. It is likely a detailed picture will emerge activity; it has been hypothesized to be involved in the over the next several years. The inhibitory actions of prefgeneration of endogenous ligands for PPAR-g (27). Ex-1, a member of the EGF-repeat family, suggest that new pression of SREBP-1c/ADD1 is also increased during osclasses of important regulatory molecules remain to be teoblast differentiation, where it is correlated with expresdiscovered. Less is known about the signaling processes sion of an osteoblastic phenotype-related gene, indicating subsequent to cell-cell or cell-matrix interactions that that increased expression of this protein is not specific to modulate transcriptional activity and adipocyte differentiadipocyte differentiation. However, this observation apation, and this area warrants future detailed examination. pears to further illustrate the close relationship between Understanding how the various molecules regulate adithe osteoblast and adipoblast lineages (228). posity and energy balance in physiological and pathophysAnother bHLH protein, twist, discussed in section III, iological situations remains an important area for future is expressed at high levels in WAT and brown adipose research and may lead to the development of novel theratissue, primarily in stromal cells. A decrease in twist expeutic approaches to human obesity. pression is observed upon differentiation of 3T3-L1 cells and primary preadipocytes. Like Ids, twist is not adipocyte ing of myogenic bHLH transcription factor to DNA (222, 254). Although modulation of twist expression during adipocyte differentiation strengthens the potential role of REFERENCES this bHLH transcription factor in adipose tissue development, its precise role in this process remains difficult to 5. ALESSI, M. C., F. PEIRETTI, P. MORANGE, M. HENRY, G. NAL-STEIN. TGF beta 1 prevents the down-regulation of type I procollagen, fibronectin, and TGF beta 1 gene expression associated with BONE, AND I. JUHAN-VAGUE. 
